OnKure Therapeutics, Inc. OKUR Quick ratio
Quick ratio at other companies
Other financials
Where this comes from
Calculated from OnKure Therapeutics, Inc.’s reported figures.
Based on the most recent quarter.
The official record: OnKure Therapeutics, Inc.’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →
Ask your AI about OnKure Therapeutics, Inc.'s quick ratio.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is OnKure Therapeutics, Inc.'s quick ratio?
- OnKure Therapeutics, Inc. (OKUR) reported quick ratio of 13.8× in Q1 2026.
- How has OnKure Therapeutics, Inc.'s quick ratio changed year-over-year?
- OnKure Therapeutics, Inc.'s quick ratio increased by 23.3% year-over-year, from 11.2× to 13.8×.
- What is the long-term trend for OnKure Therapeutics, Inc.'s quick ratio?
- Over 5 years (2020 to 2025), OnKure Therapeutics, Inc.'s quick ratio has grown at a -3.1% compound annual growth rate (CAGR), from 12× to 10.3×.
- What does quick ratio mean?
- Current assets excluding inventory, divided by current liabilities at the quarter end (the 'acid-test'). A stricter liquidity measure that excludes the least-liquid current asset.